If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Margery Mark is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Parkinson Disease Medicine & Life Sciences
Levodopa Medicine & Life Sciences
Depression Medicine & Life Sciences
Age of Onset Medicine & Life Sciences
Progressive Supranuclear Palsy Medicine & Life Sciences
Dyskinesias Medicine & Life Sciences
Parkinsonian Disorders Medicine & Life Sciences
Dihydroxyphenylalanine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

  • 5057 Citations
  • 36 h-Index
  • 62 Article
  • 2 Letter
  • 2 Review article

Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations

The AL-108-231 Study Group, The PROPSPERA investigators, 4RNTI-1authors & Tau Restoration on PSP (TAUROS) Investigators, Mar 2019, In : Parkinsonism and Related Disorders. 60, p. 138-145 8 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy
Clinical Trials
Extremities
Tauopathies
Therapeutic Uses
9 Citations (Scopus)

Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

Tau Restoration on PSP (TAUROS) Investigators & The MDS-Endorsed PSP Study Group, May 1 2016, In : Movement Disorders. 31, 5, p. 742-747 6 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy
Placebo Effect
Clinical Trials
Activities of Daily Living
England

Psychogenic parkinsonism: Clinical spectrum and diagnosis

Sage, J. & Mark, M., Jan 1 2015, In : Annals of Clinical Psychiatry. 27, 1, p. 33-38 6 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Parkinsonian Disorders
Tremor
Movement Disorders
Posture
Gait
124 Citations (Scopus)

A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

Tolosa, E., Litvan, I., Höglinger, G. U., Burn, D., Lees, A., Andrés, M. V., Gómez-Carrillo, B., León, T., Del Ser, T., Gómez, J. C., Tijero, B., Berganzo, K., García de Yebenes, J., Lopez Sendón, J. L., Garcia, G., Tolosa, E., Buongiorno, M. T., Bargalló, N., Burguera, J. A., Martinez, I. & 48 others, Ruiz-Martínez, J., Narrativel, I., Vivancos, F., Ybot, I., Aguilar, M., Quilez, P., Boada, M., Lafuente, A., Hernandez, I., López-Lozano, J. J., Mata, M., Kupsch, A., Lipp, A., Ebersbach, G., Schmidt, T., Hahn, K., Höglinger, G., Höllerhage, M., Oertel, W. H., Respondek, G., Stamelou, M., Reichmann, H., Wolz, M., Schneider, C., Klingelhöfer, L., Berg, D., Maetzler, W., Srulijes, K. K., Ludolph, A., Kassubek, J., Steiger, M., Tyler, K., Burn, D. J., Morris, L., Lees, A., Ling, H., Hauser, R., McClain, T., Truong, D., Jenkins, S., Litvan, I., Houghton, D., Ferrara, J., Bordelon, Y., Gratiano, A., Mark, M., Uitti, R. & Ven Gerpen, J., Apr 1 2014, In : Movement Disorders. 29, 4, p. 470-478 9 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy
Glycogen Synthase Kinase 3
Placebos
Safety
Apathy
12 Citations (Scopus)

Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease

Dobkin, R., Tröster, A. I., Rubino, J. T., Allen, L. A., Gara, M. A., Mark, M. & Menza, M., Jan 1 2014, In : Journal of Neuropsychiatry and Clinical Neurosciences. 26, 1, p. 57-63 7 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Parkinson Disease
Depression
Short-Term Memory
Randomized Controlled Trials
Education

Press/Media